Nitto Avecia
Matthew Pelletier is a Lead Process/Project Engineer at NITTO DENKO Avecia Inc., a position held since June 2013. Prior experience includes roles as an Engineering Intern at GVD Corporation, where skills in developing thin film polymers were honed, and as a Research Intern at Advanced Electron Beams, focusing on VOC removal systems. Additional experience includes an internship in Downstream Purification at Cubist Pharmaceuticals, where expertise in chromatography and HPLC analysis was developed. Matthew Pelletier obtained a Bachelor of Science in Chemical Engineering from Northeastern University and is currently pursuing a Master of Science in Chemical Engineering at Worcester Polytechnic Institute, expected to complete in May 2024.
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.